Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics
Pharmacology Research & Perspectives · 2024
DOI: 10.1002/prp2.1197 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, 2024. Verfasst von Genki Minegishi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biopharmaceutics, Graduate School of Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Japan. Hauptthemen laut MEDLINE: Cholic Acid, Cytochrome P-450 CYP3A, Microsomes, Liver, Cholesterol. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Science and Technology Agency, Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Human cytochrome P450 3A4 (CYP3A4) is a drug‐metabolizing enzyme that is abundantly expressed in the liver and intestine. It is an important issue whether compounds of interest affect the expression of CYP3A4 because more than 30% of commercially available drugs are metabolized by CYP3A4. In this study, we examined the effects of cholesterol and cholic acid on the expression level and activity of CYP3A4 in hCYP3A mice that have a human CYP3A gene cluster and show human‐like regulation of the coding genes. A normal diet (ND, CE‐2), CE‐2 with 1% cholesterol and 0.5% cholic acid (HCD) or CE‐2 with 0.5% cholic acid was given to the mice. The plasma concentrations of cholesterol, cholic acid and its metabolites in HCD mice were higher than those in ND mice. In this condition, the expression levels of hepatic CYP3A4 and the hydroxylation activities of triazolam, a typical CYP3A4 substrate, in liver microsomes of HCD mice were higher than those in liver microsomes of ND mice. Furthermore, plasma concentrations of triazolam in HCD mice were lower than those in ND mice. In conclusion, our study suggested that hepatic CYP3A4 expression and activity are influenced by the combination of cholesterol and cholic acid in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biopharmaceutics, Graduate School of Clinical Pharmacy, Meiji Pharmaceutical University, Kiyose, Japan.
- Chromosome Engineering Research Center (CERC), Tottori University, Tottori, Japan.
- Department of Chromosome Biomedical Engineering, Faculty of Medicine, School of Life Science, Tottori University, Tottori, Japan.
ORCID-Profile: Genki Minegishi, Kaoru Kobayashi
Förderung
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Minegishi, G., Kobayashi, Y., Fujikura, M., Sano, A., Kazuki, Y., & Kobayashi, K. (2024). Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.1197
Vancouver
Minegishi G, Kobayashi Y, Fujikura M, Sano A, Kazuki Y, Kobayashi K. Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics. Pharmacology Research & Perspectives. 2024. doi:10.1002/prp2.1197
BibTeX
@article{Minegishi2024,
author = {Minegishi, Genki and Kobayashi, Yuka and Fujikura, Mayu and Sano, Ayane and Kazuki, Yasuhiro and Kobayashi, Kaoru},
title = {Induction of hepatic CYP3A4 expression by cholesterol and cholic acid: Alterations of gene expression, microsomal activity, and pharmacokinetics},
journal = {Pharmacology Research & Perspectives},
year = {2024},
doi = {10.1002/prp2.1197}
}
EUVIMED